2006
DOI: 10.1016/j.humpath.2006.01.001
|View full text |Cite
|
Sign up to set email alerts
|

p16 expression in relation to human papillomavirus in anogenital lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
25
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(27 citation statements)
references
References 33 publications
2
25
0
Order By: Relevance
“…The percentages of lesions showing immunoreactivity for p16 increased from AIN1 to invasive cancers, the latter being all positive (Fig. 2J, K), confirming previous data [17,18]. In HIV-positive patients, the percentage of AIN2 expressing p16 was twice that in HIV-negative patients (Table 3).…”
Section: Expression Of P16 and Ki67 In Anal Lesionssupporting
confidence: 88%
See 2 more Smart Citations
“…The percentages of lesions showing immunoreactivity for p16 increased from AIN1 to invasive cancers, the latter being all positive (Fig. 2J, K), confirming previous data [17,18]. In HIV-positive patients, the percentage of AIN2 expressing p16 was twice that in HIV-negative patients (Table 3).…”
Section: Expression Of P16 and Ki67 In Anal Lesionssupporting
confidence: 88%
“…One corresponded to a mix of total genomes containing the conserved HPV region, others were specific for each type of HPV as follows: 6, 11, 16, 18, 31, or 33 [2]. If results for the latest were negative, we tested a high-risk HPV probe corresponding to a mix of 16,18,31,33,35,39,45, 51, 52, 56, 58, 59, and 68 types (Dakopatt). The signal was amplified with the biotinyl-tyramide complex, using diaminobenzidine as the chromogen (Genpoint kit, Dakopatt).…”
Section: In Situ Molecular Techniques For Hpv Detectionmentioning
confidence: 99%
See 1 more Smart Citation
“…5), as compared to the keratinizing type carcinomas of the same site [6,7,22]. This immunohistochemical profile is analogous to that seen in HPV positive anogenital carcinomas [23][24][25]. As mentioned above the majority of oropharyngeal HPVrelated lesions start at the bottom of the crypts of the palatine and lingual tonsils, and thus are inaccessible to routine cytologic smears.…”
Section: Immunohistochemistrymentioning
confidence: 58%
“…In HPV-associated tumours, the expression of tumour suppressor protein p16 INK4a is increased due to inactivation of retinoblastoma protein by high-risk HPV oncoprotein E7, unlike other cancers in which p16 INK4a gets inactivated 13 14. Overexpression of p16 INK4a is therefore considered a reliable marker for HPV-induced cervical intraepithelial neoplasia and head and neck SCC 15…”
Section: Introductionmentioning
confidence: 99%